NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 84 filers reported holding NEOS THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 938,598 | $13,105,000 | 6.84% |
| Sio Capital Management, LLC | 781,514 | $11,191,000 | 4.96% |
| DAFNA Capital Management LLC | 63,400 | $908,000 | 0.81% |
| WALL STREET ASSOCIATES | 149,343 | $2,139,000 | 0.60% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 412,058 | $5,901,000 | 0.31% |
| NEXTHERA CAPITAL LP | 15,000 | $215,000 | 0.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 458,332 | $6,563,000 | 0.27% |
| EMERALD ADVISERS, LLC | 378,874 | $5,425,000 | 0.26% |
| Perceptive Advisors | 142,603 | $2,042,000 | 0.15% |
| Cormorant Asset Management, LP | 50,000 | $716,000 | 0.09% |